UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 79

Sortiert nach

Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial

Journal of clinical oncology, 2020-11, Vol.38 (31), p.3592-3603

2020

Link zum Volltext

Verfügbarkeit prüfen

Continuous hypertonic saline therapy and the occurrence of complications in neurocritically ill patients

Critical care medicine, 2009-04, Vol.37 (4), p.1433-1441

2009

Link zum Volltext

Verfügbarkeit prüfen

Effect of early nutrition on deaths due to severe traumatic brain injury

Journal of neurosurgery, 2008-07, Vol.109 (1), p.50-56

2008

Link zum Volltext

Verfügbarkeit prüfen

Meta‐analysis of sentinel lymph node positivity in thin melanoma (≤1 mm)

Cancer, 2009-02, Vol.115 (4), p.869-879

2009

Link zum Volltext

Verfügbarkeit prüfen

The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state

The journal of clinical psychiatry, 2012-04, Vol.73 (4), p.498

2012

Link zum Volltext

Verfügbarkeit prüfen

The Role of Herpes Simplex Virus Type 2 and Other Genital Infections in the Acquisition of HIV-1 among High-Risk Women in Northern Tanzania

The Journal of infectious diseases, 2007-05, Vol.195 (9), p.1260-1269

2007

Link zum Volltext

Verfügbarkeit prüfen

Deceased-donor kidney transplantation: improvement in long-term survival

Nephrology, dialysis, transplantation, 2011, Vol.26 (1), p.317-324

2011

Link zum Volltext

Verfügbarkeit prüfen

Impact of onabotulinumtoxinA on quality of life and practical aspects of daily living: A pooled analysis of two randomized controlled trials

International journal of urology, 2015-12, Vol.22 (12), p.1131-1137

2015

Link zum Volltext

Verfügbarkeit prüfen

Total, primary, and secondary serum bile acid changes and pruritus improvement during odevixibat treatment in patients with progressive familial intrahepatic cholestasis

Journal of hepatology, 2022-07, Vol.77, p.S517-S518

2022

Link zum Volltext

Verfügbarkeit prüfen

Feasibility of using audio computer-assisted self-interview (ACASI) screening in routine HIV care

AIDS care, 2009-08, Vol.21 (8), p.992-999

2009

Link zum Volltext

Verfügbarkeit prüfen

Improvements in quality of life in odevixibat responders and nonresponders: an analysis of pooled data from the PEDFIC 1 and PEDFIC 2 studies

Journal of hepatology, 2022-07, Vol.77, p.S517

2022

Link zum Volltext

Verfügbarkeit prüfen

EP1230: EFFICACY AND SAFETY OF ODEVIXIBAT IN CHILDREN WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS WITH PRIOR PARTIAL EXTERNAL BILIARY DIVERSION

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-1296

2022

Link zum Volltext

Verfügbarkeit prüfen

TOP-057 - Long-term efficacy and safety of odevixibat in patients with progressive familial intrahepatic cholestasis: results with 96 weeks or more of treatment

Journal of hepatology, 2023-06, Vol.78, p.S938-S938

2023

Link zum Volltext

Verfügbarkeit prüfen

Long-term efficacy and safety of odevixibat in patients with progressive familial intrahepatic cholestasis: results with 96 weeks or more of treatment

Journal of hepatology, 2023-06, Vol.78, p.S938

2023

Link zum Volltext

Verfügbarkeit prüfen

Real world treatment (tx) patterns and total cost of care among patients (pts) receiving nab -paclitaxel+carboplatin ( nab -P/C) versus sb-paclitaxel+carboplatin (sb-P/C) as first line (1L) tx for metastatic non-small cell lung cancer (mNSCLC)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e18274-e18274

2016

Link zum Volltext

Verfügbarkeit prüfen

EP1233: LONG-TERM TREATMENT WITH ODEVIXIBAT IMPROVES MULTIPLE SLEEP PARAMETERS IN PATIENTS WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS: A POOLED RESPONDER ANALYSIS FROM THE PHASE 3 PEDFIC STUDIES

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-1297

2022

Link zum Volltext

Verfügbarkeit prüfen

Treatment Patterns and Clinical and Economic Outcomes in Patients With Newly Diagnosed Multiple Myeloma Treated With Lenalidomide- and/or Bortezomib-containing Regimens Without Stem Cell Transplant in a Real-world Setting

Clinical lymphoma, myeloma and leukemia, 2019-10, Vol.19 (10), p.645-655

2019

Link zum Volltext

Verfügbarkeit prüfen

Maintenance (MT) treatment (Tx) after lenalidomide, bortezomib, and dexamethasone (RVD) induction and stem cell transplant (SCT) in high-risk (HR) patients (pts) with newly diagnosed multiple myeloma (NDMM): A real-world analysis

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e20041-e20041

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Economic Burden of Transfusion-Dependent β-Thalassemia in Adult Patients in the United States

Blood, 2017-12, Vol.130, p.2095-2095

2017

Link zum Volltext

Verfügbarkeit prüfen

EP1231: ODEVIXIBAT THERAPY IMPROVES CLINICALLY MEANINGFUL ENDPOINTS IN CHILDREN WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS: DATA FROM THE PEDFIC 1 AND PEDFIC 2 TRIALS

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-1296

2022

Link zum Volltext

Verfügbarkeit prüfen

EP1228: DISEASE BURDEN AND NATURAL HISTORY OF PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS: BASELINE CLINICAL CHARACTERISTICS AMONG ODEVIXIBAT-TREATED PATIENTS IN THE PHASE 3 PEDFIC STUDIES

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-1295

2022

Link zum Volltext

Verfügbarkeit prüfen

Total healthcare, treatment, and supportive care costs among metastatic pancreatic cancer (MPC) patients (pts) treated with either nab-paclitaxel/gemcitabine ( nab -P+G) or FOLFIRINOX (FFX) in the first-line (1L) setting

Journal of clinical oncology, 2017-03, Vol.35 (8_suppl), p.20-20

2017

Link zum Volltext

Verfügbarkeit prüfen

PD1-01 LONG-TERM EFFICACY AND SAFETY OF ONABOTULINUMTOXINA IN PATIENTS WITH NEUROGENIC DETRUSOR OVERACTIVITY: ANALYSIS AMONG PATIENTS WHO COMPLETED 4 YEARS OF TREATMENT

The Journal of urology, 2015, Vol.193 (4), p.e35-e35

2015

Link zum Volltext

Verfügbarkeit prüfen

Economic burden of early progression in newly-diagnosed multiple myeloma patients

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e20040-e20040

2018

Link zum Volltext

Verfügbarkeit prüfen

EP1229: RELATIONSHIPS BETWEEN DECREASES IN SERUM BILE ACIDS, PRURITUS, AND SLEEP DISTURBANCE SCORES WITH UP TO 72 WEEKS OF ODEVIXIBAT TREATMENT IN PATIENTS WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-1295-S-1296

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(74)

Publikationsform

Artikel
(78)
Tagungsberichte
(1)

Sprache

Englisch
(79)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(29)
Humans
(18)
Female
(15)
Male
(14)
Middle Aged
(14)
Biological And Medical Sciences
(12)
Chemistry
(11)
Physical Sciences
(11)
Adult
(10)
Medical Sciences
(9)
Aged
(6)
Chemistry, Applied
(6)
Oncology
(6)
Cucurbita - Chemistry
(5)
Food Science & Technology
(5)
Pumpkins
(5)
Time Factors
(5)
Fundamental And Applied Biological Sciences. Psychology
(4)
Infectious Diseases
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial

Continuous hypertonic saline therapy and the occurrence of complications in neurocritically ill patients

Effect of early nutrition on deaths due to severe traumatic brain injury

Meta‐analysis of sentinel lymph node positivity in thin melanoma (≤1 mm)

The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state

The Role of Herpes Simplex Virus Type 2 and Other Genital Infections in the Acquisition of HIV-1 among High-Risk Women in Northern Tanzania

Deceased-donor kidney transplantation: improvement in long-term survival

Impact of onabotulinumtoxinA on quality of life and practical aspects of daily living: A pooled analysis of two randomized controlled trials

Total, primary, and secondary serum bile acid changes and pruritus improvement during odevixibat treatment in patients with progressive familial intrahepatic cholestasis

Feasibility of using audio computer-assisted self-interview (ACASI) screening in routine HIV care

Improvements in quality of life in odevixibat responders and nonresponders: an analysis of pooled data from the PEDFIC 1 and PEDFIC 2 studies

EP1230: EFFICACY AND SAFETY OF ODEVIXIBAT IN CHILDREN WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS WITH PRIOR PARTIAL EXTERNAL BILIARY DIVERSION

TOP-057 - Long-term efficacy and safety of odevixibat in patients with progressive familial intrahepatic cholestasis: results with 96 weeks or more of treatment

Long-term efficacy and safety of odevixibat in patients with progressive familial intrahepatic cholestasis: results with 96 weeks or more of treatment

Real world treatment (tx) patterns and total cost of care among patients (pts) receiving nab -paclitaxel+carboplatin ( nab -P/C) versus sb-paclitaxel+carboplatin (sb-P/C) as first line (1L) tx for metastatic non-small cell lung cancer (mNSCLC)

EP1233: LONG-TERM TREATMENT WITH ODEVIXIBAT IMPROVES MULTIPLE SLEEP PARAMETERS IN PATIENTS WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS: A POOLED RESPONDER ANALYSIS FROM THE PHASE 3 PEDFIC STUDIES

Treatment Patterns and Clinical and Economic Outcomes in Patients With Newly Diagnosed Multiple Myeloma Treated With Lenalidomide- and/or Bortezomib-containing Regimens Without Stem Cell Transplant in a Real-world Setting

Maintenance (MT) treatment (Tx) after lenalidomide, bortezomib, and dexamethasone (RVD) induction and stem cell transplant (SCT) in high-risk (HR) patients (pts) with newly diagnosed multiple myeloma (NDMM): A real-world analysis

Clinical and Economic Burden of Transfusion-Dependent β-Thalassemia in Adult Patients in the United States

EP1231: ODEVIXIBAT THERAPY IMPROVES CLINICALLY MEANINGFUL ENDPOINTS IN CHILDREN WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS: DATA FROM THE PEDFIC 1 AND PEDFIC 2 TRIALS

EP1228: DISEASE BURDEN AND NATURAL HISTORY OF PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS: BASELINE CLINICAL CHARACTERISTICS AMONG ODEVIXIBAT-TREATED PATIENTS IN THE PHASE 3 PEDFIC STUDIES

Total healthcare, treatment, and supportive care costs among metastatic pancreatic cancer (MPC) patients (pts) treated with either nab-paclitaxel/gemcitabine ( nab -P+G) or FOLFIRINOX (FFX) in the first-line (1L) setting

PD1-01 LONG-TERM EFFICACY AND SAFETY OF ONABOTULINUMTOXINA IN PATIENTS WITH NEUROGENIC DETRUSOR OVERACTIVITY: ANALYSIS AMONG PATIENTS WHO COMPLETED 4 YEARS OF TREATMENT

Economic burden of early progression in newly-diagnosed multiple myeloma patients

EP1229: RELATIONSHIPS BETWEEN DECREASES IN SERUM BILE ACIDS, PRURITUS, AND SLEEP DISTURBANCE SCORES WITH UP TO 72 WEEKS OF ODEVIXIBAT TREATMENT IN PATIENTS WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS

Suchergebnisse filtern